Rhythm Pharmaceuticals (RYTM) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to -$780.1 million.
- Rhythm Pharmaceuticals' Enterprise Value fell 16102.35% to -$780.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$780.1 million, marking a year-over-year decrease of 16102.35%. This contributed to the annual value of -$321.0 million for FY2024, which is 1624.16% down from last year.
- As of Q3 2025, Rhythm Pharmaceuticals' Enterprise Value stood at -$780.1 million, which was down 16102.35% from -$446.4 million recorded in Q2 2025.
- Rhythm Pharmaceuticals' Enterprise Value's 5-year high stood at -$201.7 million during Q1 2024, with a 5-year trough of -$780.1 million in Q3 2025.
- In the last 5 years, Rhythm Pharmaceuticals' Enterprise Value had a median value of -$319.6 million in 2024 and averaged -$345.9 million.
- Per our database at Business Quant, Rhythm Pharmaceuticals' Enterprise Value crashed by 62104.88% in 2021 and then soared by 4043.32% in 2022.
- Over the past 5 years, Rhythm Pharmaceuticals' Enterprise Value (Quarter) stood at -$295.2 million in 2021, then dropped by 13.02% to -$333.6 million in 2022, then increased by 17.22% to -$276.2 million in 2023, then decreased by 16.24% to -$321.0 million in 2024, then plummeted by 142.99% to -$780.1 million in 2025.
- Its Enterprise Value was -$780.1 million in Q3 2025, compared to -$446.4 million in Q2 2025 and -$522.9 million in Q1 2025.